循环肿瘤反应性 T 细胞的表型预测非小细胞肺癌免疫检查点抑制剂疗效
Phenotype of circulating tumor-reactive T cells predicts immune checkpoint inhibitor response in non-small cell lung cancer.
78.6分
★★★★☆
站内排序·非疗效
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
FRONTIER PAPERS
前沿论文 15
条件筛选 · 已选 2 项 · 共 15 条展开收起
具有 CD38(-)CD73(-)Tim-3(-)HLA-DR(+) 表型的 CAR-T 细胞预测 tisagenlecleucel 治疗 B 细胞前体 ALL 的疗效
CAR-T cells with the CD38(-)CD73(-)Tim-3(-)HLA-DR(+) phenotype predict the efficacy of tisagenlecleucel as a treatment for B cell precursor ALL.
77.1分
★★★★☆
站内排序·非疗效
47.2分
★★★☆☆
站内排序·非疗效
维奈克拉与达雷妥尤单抗对多发性骨髓瘤中抗体依赖性细胞介导的 NK 细胞毒作用的协同效应
Synergistic Effects of Venetoclax and Daratumumab on Antibody-Dependent Cell-Mediated Natural Killer Cytotoxicity in Multiple Myeloma.
46.9分
★★★☆☆
站内排序·非疗效
抗 CD38 单克隆抗体 Daratumumab 抗原发性渗出性淋巴瘤的疗效与机制
Efficacy and mechanism of the anti-CD38 monoclonal antibody Daratumumab against primary effusion lymphoma.
46.9分
★★★☆☆
站内排序·非疗效
异基因造血细胞移植后高度难治性多发性骨髓瘤与治疗相关 MDS/AML 的持久缓解：CAR-T 时代其作用的再思考
Durable Remission of Highly Refractory Multiple Myeloma and Therapy-Related MDS/AML After Allogeneic Hematopoietic Cell Transplantation: Reconsidering
35.1分
★★☆☆☆
站内排序·非疗效
哺乳动物 SWI/SNF 复合物亚基基因突变对免疫肿瘤微环境的影响
Impact of Mutations in Subunit Genes of the Mammalian SWI/SNF Complex on Immunological Tumor Microenvironment.
32.0分
★☆☆☆☆
站内排序·非疗效
抗 BCMA CAR-T 细胞治疗复发/难治性多发性骨髓瘤的成本效果
Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma.
32.0分
★☆☆☆☆
站内排序·非疗效
在单克隆抗体时代接受 VTD-PACE 治疗的复发/难治性多发性骨髓瘤患者的真实世界临床结局
Real-world clinical outcomes in patients with relapsed and refractory multiple myeloma receiving VTD-PACE treatment in the era of monoclonal antibodie
31.6分
★☆☆☆☆
站内排序·非疗效
复发性及难治性多发性骨髓瘤：新型疗法疗效的系统评价和网络 meta 分析
Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapies.
31.6分
★☆☆☆☆
站内排序·非疗效